CONMED Corporation announced its financial results for the second quarter ended June 30, 2025. Net sales for the quarter reached $342.3 million, an increase of 3.1% year-over-year as reported and 2.9% in constant currency. Diluted EPS was $0.69, compared to $0.96 in Q2 2024, while adjusted diluted EPS was $1.15.
The company updated its full-year 2025 outlook, raising its reported revenue guidance to between $1.356 billion and $1.378 billion, up from the prior range of $1.350 billion and $1.378 billion. Full-year adjusted diluted net earnings per share guidance was also raised to a range of $4.40 to $4.55, from the prior range of $4.31 to $4.46.
The updated guidance for adjusted diluted EPS includes an estimated negative impact of approximately $0.09 in the second half of 2025 due to recent tariff announcements. Management noted continued efforts to strengthen supply chain operations and expressed confidence in the long-term potential of its four key growth drivers.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.